[1] Joseph A, James J, Richard CK, et al. Oral pathology clinical pathologyic correlation[M]. Fourth edition. St. Lalis: Saunders, 1992(1):75-77.
[2] Arduino PG,Bagan J,El-Naggar AK,et al. Urban legends series:oral leukoplakia[J]. Oral Dis, 2013, 19(7):642-659.
[3] 周曾同, 刘伟. 口腔癌前病变的癌变风险预测[J]. 实用肿瘤杂志, 2015, 30(1):4-7.
[4] Scully C, Sudbo J, Speight PM. Progress in determining the malignant potential of oral lesions[J]. J Oral Pathol Med, 2003, 32(5):251-256.
[5] World Health Organization Classification of Tumours. Pathology and genetics. Head and neck tumours. International Agency for Research on Cancer (IARC). In: Barnes L, Eveson JW, Reichart P, Sidransky D, eds. Head and neck tumors. Lyon: IARC Press, 2005:177-180.
[6] Tabor MP, Braakhuis BJ, van der Wal JE, et al. Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx[J]. J Pathol, 2003,199(3):354-360.
[7] Fischer DJ, Epstein JB, Morton TH, et al. Interobserver reliability in the histopathologic diagnosis of oral pre-malignant and malignant lesions[J]. J Oral Pathol Med, 2004, 33(2): 65-70.
[8] Mattila R, Alanen K, Syrj?覿nen S. Immunohistochemicalstudy onTopoisomerase llalpha, Ki-67 and cytokeratin-19 in oral lichen Planus lesions[J]. Arch Dermatol Res, 2007, 298(8):381-388.
[9] 黄沂传, 李鹏, 徐艳丽, 等. CK4与CK13在喉咽鳞状细胞癌中的表达及其临床意义[J]. 临床耳鼻咽喉头颈外科杂志, 2014, 28(12):874-877.
[10] Kujan O, Khattab A, Oliver RJ, et al. Why oral histopathology suffers inter-observer variability on grading oral epithelial dysplasia: an attempt to understand the sources of variation[J]. Oral Oncol, 2007, 43(3):224-231.
[11] 周曾同,钟文静,周永梅,等.口腔黏膜上皮异常增生光镜观察及分级的误差分析[J].华夏医学,1999(06):668-670.
[12] Kujan O, Oliver RJ, Khattab A,et al,Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation[J]. Oral Oncol, 2006, 42(10):987-993.
[13] Pillai K, Pourgholami MH, Chua TC, et al. Prognosticsignificance of Ki67 expression in malignant peritonealmesothelima[J]. Am J Clin Oncol,2015,38(4):388-394.
[14] 徐婷, 何奇, 吴克瑾, 等. 三阴性乳腺癌中P53和Ki67表达的相关研究[J]. 上海交通大学学报(医学版), 2013, 33(6):833-837.
[15] 何伟, 陈欢, 陈卫民. Cyclin D1、Ki-67在口腔黏膜白斑和口腔鳞癌中的表达[J]. 河北联合大学学报(医学版), 2016, (18)2:139-141,144.
[16] Denkert C, Loibl S, Muller BM, et al. Ki-67 Levels aspredictive and Prognostic parameters in pretherapeutic breastcancer core biopsies: a translational investigation in theneoadjuvant GeparTrio trial[J]. Ann Oncol, 2013, 24(11):2786-2793.
[17] Kurokawa H, Matsumoto S, Murata T, et al. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia[J]. J Oral Pathol Med, 2003, 32(9):513-521.
[18] Saito T, Nakajima T, Mogi K. Immunohistochemical analysis of cell cycle-associated proteins p16, pRb, p53, p27 and Ki-67 in oral cancer and precancer with special reference to verrucous carcinomas[J]. J Oral Pathol Med, 1999, 28(5):226-232.
[19] Girod SC, Krueger G, Pape HD. p53 and Ki67 expression in preneoplastic and neoplastic 1essions of the oral mucosa[J]. Int J Oral Maxillofac Surg, 1993, 22(6):285-288.
[20] Lu DP, Tatemoto Y, Yokoyama T, et al. Cy-tokerratin expression Patterns in jaw cyst linings with metaplastic epithelium[J]. Oral PatholMed, 2002, 31(2):87-94.
[21] Klijanienko J, Micheau C, Carlu C, et al. Significance of keratin 13 and 6 expression in normal, dysplasic and malignant squamous epithelium of pyriform fossa[J]. Virchows Archiv-A Pathol Aant Histopathol, 1989, 416(2):121-124.
[22] 邱元正, 田勇泉, 肖健云, 等. 细胞角蛋白基因13在鼻咽癌中的表达研究[J]. 中华肿瘤杂志, 2000, 22(2):41-43,91.
[23] Yanagawa T, Yoshida H, Yamagata K, et al. Loss of cytokerratin 13 expression in squamouscell carcinoma of the tongue is a possible sign for localrecurrence[J]. J Exp Clin Cancer Res, 2007, 26:215-220. |